Anti-IgE monoclonal antibody (omalizumab) treatment increases blood glucose levels in severe persistent allergic asthma patients with type 2 diabetes
World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, Italy, 22 - 26 June 2013, vol.68, pp.364
- Publication Type: Conference Paper / Summary Text
- Volume: 68
- City: Milan
- Country: Italy
- Page Numbers: pp.364
- Akdeniz University Affiliated: Yes